1Patent analysis for PARP inhibitor olaparibLU Yi, YU Hao, HUANG Lu1281-12862Analysis of patent application situation of ertugliflozinZHANG Lei, MAO Dan1287-12913Enlightenment of American MTM model to the construction of pharmaceutical service capability in primary medical institutions in ChinaZHAO Wen-min, YANG Yi, TIAN Kan1292-12964Discussion on cell therapy regulatory policy of China, USA and EUWANG Qing-qing, WANG Chong, HUANG Zhi-hong1297-13025Pharmacological and clinical evaluation of elagolix in the treatment of endometriosisLI Chun-xing, LIU Hua1303-13066Case analysis of organic impurities analysis and control in chemical genericsZHANG Jun-lin, HE Wu1307-13117Study the hepatotoxicity of monoanthranone with emodin-type using in vitro 3D liver modelDAN Mo, LIU Dong, HUANG Shu-jia, WANG Yu, WANG Qi, ZHAO Yan-yan1312-13178Evaluation of pharmacokinetics and pharmacodynamic indicators of octreotide acetate sustained release microspheres in ratsWANG Lei, SHA Chun-jie, YU Fei, LENG Guang-yi, SHAO Xin, YANG Hui-jie, LIU Fang-jie, LIU Wan-hui1318-13249PDZ domains can serve as a target for developing new drugsZHU Zhi-ying, QIN Ya-juan, LI Ting-you1325-132910Progress in numerical simulation technology for fluidized bed granulationZENG Jia, HUANG Ting, FENG Ling-lin, XUE Man, CHEN Jian-xing, DU Ruo-fei, FENG Yi1330-134211Advances in the treatment of multiple myeloma with chromosome 1q21 amplificationLIU Ying, CHEN Jian-bin1343-134712Implement and improvement suggestions of randomization in the process of traditional Chinese medicine clinical trailsLI Hong-zheng, LI Bo, ZHAO Guo-zhen1348-135413Analysis on ethical review of noncompliance/violation protocol report in drug clinical researchCAO Wei, WANG Dan-ping1355-135914Protective effects of total saponin of Aralia taibaiensis against cerebral ischemia/reperfusion injuryLIU Xue-hong, PAN Yang, WANG Jian-bo1360-136515Study on quality standard of Fuzhengtongluo granulesCAO Zhang-qi, XU Jing-wen, LU Li, HU Yan, LUO Zhen, LI Hong-yuan, WANG Xue-xi1372-137716Preventive effects of p-coumaric acid on acute hypoxia-induced cerebral edema in miceCHU Bing-quan, LI Yun-hong, LI Jiao-jie, CHEN Xiao-jian, GONG Jin-yan, ZHANG Ying1378-138417Improvement of doxercalciferol synthetic processYANG Xiao-yu, ZHANG Guo-ning, WANG Ju-xian1385-139018Research of compound-target-cardio-cerebral vascular disease network pharmacology of Paeoniae Radix Rubra based on random forest algorithmYUAN Jie, HE Hong, ZHANG Wei-jin1391-139619Ocrelizumab in the treatment of relapsing multiple sclerosis: a Meta-analysisMA Li-hua, SUN Meng-jiao, YUAN Bo-yao, WANG Man-xia1397-140320PD-1/PD-L1 inhibitors associated with myocarditis-signal mining based on the three international spontaneous reporting systems in real worldWANG Xiao-xiao, CHEN Wan-yi1404-1408 